Contrarian Corpus
short seller research note initial thesis
2020-11-11 · 14 pages

MultiPlan Corp MPLN

MultiPlan is a financially-engineered SPAC corpse losing its biggest customer UHC to UHC's own competitor Naviguard; expect 35% revenue loss and 8x+ leverage by 2022.

N 4 Narrative
V 2 Visual
C 2 Craft
Source URL unavailable

Thesis

Muddy Waters is short MultiPlan Corp (MPLN), the post-SPAC vehicle birthed by Churchill Capital III and Hellman & Friedman after four consecutive private-equity owners stripped the business. The core thesis is that UnitedHealthcare, MPLN's largest customer at 35% of 2019 revenue, has incubated a direct competitor called Naviguard that prices 30-40% below MPLN, eliminates conflicts of interest, and protects members from balance billing. Muddy Waters projects Naviguard will erase $385.8M of revenue and $294.2M of EBITDA by 2022, pushing net leverage above 8.0x and cutting Levered Free Cash Flow 80% to just $74.3M. They further allege MPLN engineered 2018 EBITDA growth by slashing revenue reserves from ~30% to ~10%, masking a business in decline since 2017, and that H&F's $140M HST acquisition is a desperate stand-in for the lost Naviguard-vulnerable revenue.

SCQA

Situation

MultiPlan is an out-of-network claims-pricing middleman that went public in late 2020 via Churchill Capital III's SPAC, after 14 years and four consecutive PE owners, with Hellman & Friedman retaining a stake.

Complication

MPLN's largest client UnitedHealthcare has built Naviguard, a free, conflict-free competitor priced 30-40% lower, and management has obscured a multi-year decline through engineered revenue-reserve releases.

Resolution

Short MPLN equity and credit; Muddy Waters expects Naviguard to convert all key UHC accounts by year-end 2022 and other carriers to follow, with no acquisition able to plug the hole.

Reward

MPLN revenue falls 35% short of 2022E forecasts, EBITDA drops $294M, Levered FCF collapses 80% to $74.3M, and net leverage balloons past 8.0x — a structure Muddy Waters believes carries bankruptcy risk.

The three reasons

  1. 1

    MPLN is losing largest client UHC to UHC-built competitor Naviguard with 30-40% pricing advantage

  2. 2

    Revenue reserves dropped 30% to 10% in 2018 to engineer EBITDA growth amid shrinking sales

  3. 3

    H&F-led SPAC exit leaves 8x+ leverage as 35% of revenue and 80% of FCF disappear by 2022

KPIs cited

Revenue concentration
UHC = 35% of 2019 revenue; 85.7% of MPLN revenue addressed by Naviguard
2022E revenue impact
$385.8M lost revenue (-35.1% vs. forecast)
2022E EBITDA impact
$294.2M erosion (-35.1% vs. forecast)
Net leverage
5.9x pro forma 2019 rising to 7.3x in 2021E and >8.0x in 2022E
Levered Free Cash Flow
$74.3M in 2022E, ~80% below management's implied number
Adjusted EBITDA margin
76.3% explained by minimal human intervention in Data iSight pricing tool
Revenue reserves
Dropped from ~30% to ~10% of revenue in 2018, enabling EBITDA growth on declining sales
Naviguard pricing advantage
30-40% cheaper than MPLN per Naviguard pilot involving 125,000 UHC members
MPLN take rate
Cut roughly in half from ~12% to ~6% by national health plans in recent years
HST acquisition cost
$140M for ~550,000 covered lives = $250 per covered life

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Notable slides (5)

Notes

Muddy Waters short report (research_note format) authored by Carson Block. Word-processor style memo with footnoted sourcing, signed by Director of Research on cover. Memorable rhetorical framing: 'Private Equity Necrophilia Meets The Great 2020 Money Grab' — coined the 'PE necrophilia' label for fourth-consecutive-PE-owner SPAC exits. Heavy use of anonymous former-executive interviews (Executives A and B) and CEO quote contradictions from MPLN Analyst Day. Sum-of-parts table on p.9 quantifies which segments are vulnerable to Naviguard (85.7% of revenue). No formal target price; thesis is short equity AND credit. Stake not disclosed (typical for Muddy Waters short reports beyond standard 'we are short' admission). Visual production is institutional but text-heavy; only ~3 charts/tables across 14 pages.